본문 바로가기
KERD
논문KCI 등재

Gender difference in the association of metabolic syndrome with hs-CRP Concentration of Blood

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류기타자연과학

초록

.

Abstract

The high sensitivity C-reactive protein (hs-CRP) as one of the typical acute phase reactants is used for predictive factor of the cardiovascular disease and diabetes mellitus. In addition, there are claims that must be included as factors of metabolic syndrome. This research examined the relationship between the concentration of hs-CRP in blood and risk factors of the metabolic syndrome by gender, and the rates of metabolic syndrome depending on the hs-CRP level based on the general public who took the comprehensive medical check-up at Chonbuk National University Hospital in the Jeonbuk province. The subjects aged 17-87 years were participated, and 2,000 people were included as the final subjects except the persons with more than 10 mg/L of the hs-CRP of blood level. The hs-CRP concentrations increased according to the number of risk factors of metabolic syndrome in both men and women. In regards to the risk ratio of metabolic syndrome based on hs-CRP level in blood according to gender, the risk ratio increased by 3.07 times in male and 4.55 times in female intermediate risk group and 3.60 times in male and 6.15 times in female high risk group compared to hs-CRP low risk group. As a result, there was a proportional relation between hs-CRP level and the occurrence of metabolic syndrome, and it occurs more frequently among women than men.

참고문헌 (32)

  1. Aguilar D, "Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease", Am Heart J, 152, pp.298~304 (2006)
  2. Albert MA, "The role of C-reactive protein in cardiovascular disease risk", Curr Cardiol Rep, 2(4), pp.274~279 (2000)
  3. Baumann H, "The acute phase response", Immunol Today, 15, pp.74~80 (1994)
  4. Blake GJ, "C-reactive protein and other inflammatory risk markers in acute coronary syndrome", J Am College Cardiology, 41(4), pp.37~42 (2007)
  5. Castelli WP, "Cholesterol and lipids in the risk of coronary heart disease: The framingham heart study", Can J Cardiol, 4, pp.5A~10A (1998)
  6. Freeman DJ, "C-Reactive protein is an independent predictor of risk for the development of diabetes in the west of scotland coronary prevention study", Diabetes, 51(5), pp.1596~1600 (2002)
  7. Frohlich M, "Association between C-reactive protein and features of the metabolic syndrome: a population-based study", Diabetes Care, 23(12), pp.1835~1839 (2000)
  8. Grundy SM, "American heart association; national heart, lung, and blood institute, diagnosis and management of themetabolic syndrome: an American heart association", national heart, lung, and blood institude scientific statement, 2005, pp.112, 2735~2752
  9. Haffner SM, "The insulin resistance syndrome revisited", Diabetes Care, 19, pp.275~277 (1996)
  10. Hotamisligil GS, "Adipose expression of tumor necrosis factor-alpha: direct role in obesitylinked insulin resistance", Science, 259, pp.87~91 (1993)
  11. Imperatore G, "Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study", Diabetes Care, 21, pp.649~654 (1998)
  12. Isomaa P, "Cardiovascular morbidity and associated with the metabolic syndrome", Diabetes Care, 24(4), pp.683~689 (2001)
  13. 김종임, "일부 농촌지역 주민들의 혈중 hs-CRP 농도와 대사증후군 위험인자와의 관계", 대한지역사회영양학회지, 15(6), pp.796~805 (2010), 대한지역사회영양학회
  14. "Current data of HDL in Korean and new proposal to define role of HDL in Korean" (2007)[URL]
  15. Koenig W, "C-Reactive protein, a sensitive marker of infl ammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992", Circulation, 99, pp.237~242 (1999)
  16. Lim S, "Submitted to journal of endocrinological investigation a ruralurbancomparison of the characteristics of metabolic syndromeby gender in Korea: The Korea Health and Denome Study (KHGS)", J Endocrinol Invest, 29(4), pp.303~319 (2006)
  17. Marroquin OC, "Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: A report from the women’’s ischemia syndrome evaluation", Circulation, 109(6), pp.714~721 (2004)
  18. McNeill AM, "The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study", Diabetes Care, 28(2), pp.385~390 (2005)
  19. Meshkani R, "The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance", Clin Chim Acta, 371(2), pp.169~175 (2006)
  20. Mohamed-Ali V, "Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo", J Clin Endocrinol Metab, 82, pp.4196~4200 (1997)
  21. Nakanishi N, "Association between fasting glucose and C-reactive protein in a Japanese population: the Minoh study", Diabetes Research and Clinical Practice, 69(1), pp.88~98 (2005)
  22. Pearson TA, "Markers of inflamation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American heart association", Circulation, 107(3), pp.499~511 (2003)
  23. Reaven GM, "Role of insulin resistance in human disease", Diabetes, 37(12), pp.1595~1607 (1998)
  24. Ridker PM, "C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women", Circulation, 107(3), pp.391~397 (2003)
  25. Ridker PM, "Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease", JAMA, 285(19), pp.2481~2485 (2001)
  26. Ridker PM, "Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk", Circulation, 109(23), pp.2818~2825 (2004)
  27. Roberts WL, "CDC", AHA wirkshop on marlers of inflammation and cardiovascular disease: Application to clinical and public health practice: laboratory tests available to assess inflammation-performance and standardization, 2004, pp.110(25), 572~576
  28. Rohde LE, "Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men", Am J Cardiol, 84, pp.1018~1022 (1999)
  29. Solymoss BC, "Effect of increasing metabolic syndrome score on atherosclerotic risk profil and coronary artery disease angiographic severity", Am J Cardiol, 93(2), pp.159~164 (2004)
  30. Sower JR, "Obesity as a cardiovascular risk factors", Am J Med, 115(8A), pp.37~44 (2003)
  31. Stern MP, "Identification of persons at high risk for type 2 diabetes mellitus: Do we need the oral glucose tolerance test", Ann Inter Med, 136(8), pp.575~581 (2002)
  32. Tracy RP, "Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the cardiovascular health study and the rural health promotion project", Arterioscler Th romb Vasc Biol, 17, pp.1121~1127 (1997)

관련 논문AI추천

이 간행물의 다른 논문 (7건)